# Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

> **NCT00002552** · PHASE2 · COMPLETED · sponsor: **Barbara Ann Karmanos Cancer Institute** · enrollment: 40 (estimated)

## Conditions studied

- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** sargramostim
- **DRUG:** carmustine
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** etoposide
- **DRUG:** leucovorin calcium
- **DRUG:** methotrexate
- **DRUG:** perfosfamide
- **DRUG:** therapeutic hydrocortisone
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** in vitro-treated bone marrow transplantation
- **PROCEDURE:** peripheral blood stem cell transplantation
- **PROCEDURE:** syngeneic bone marrow transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002552
- **Lead sponsor:** Barbara Ann Karmanos Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-10
- **Primary completion:** 2001-09
- **Final completion:** 2003-10
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002552, "Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00002552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*